Startup Vima Adds Parkinson’s to Movement Disorder Scope, Expanding Series A Round to $100M – MedCity News
When Vima Therapeutics launched last year to take its drug candidate into human testing, the lead indication was isolated dystonia,…
When Vima Therapeutics launched last year to take its drug candidate into human testing, the lead indication was isolated dystonia,…
Claudia Glass, co-founder and CEO of sports apparel company Swijin, has stood out from among more than 10,000 candidates that…
Apparel Startup XX-XY Athletics Is on a Mission to ‘Save Women’s Sports.’ Critics Say It Is Cashing In on the…